Works by Weisel, Katja C.


Results: 32
    1
    2
    3
    4

    Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00772-9
    By:
    • Mai, Elias K.;
    • Huhn, Stefanie;
    • Miah, Kaya;
    • Poos, Alexandra M.;
    • Scheid, Christof;
    • Weisel, Katja C.;
    • Bertsch, Uta;
    • Munder, Markus;
    • Berlanga, Oscar;
    • Hose, Dirk;
    • Seckinger, Anja;
    • Jauch, Anna;
    • Blau, Igor W.;
    • Hänel, Mathias;
    • Salwender, Hans J.;
    • Benner, Axel;
    • Raab, Marc S.;
    • Goldschmidt, Hartmut;
    • Weinhold, Niels
    Publication type:
    Article
    5

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    6

    Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0273-x
    By:
    • Dimopoulos, Meletios A.;
    • Jakubowiak, Andrzej J.;
    • McCarthy, Philip L.;
    • Orlowski, Robert Z.;
    • Attal, Michel;
    • Bladé, Joan;
    • Goldschmidt, Hartmut;
    • Weisel, Katja C.;
    • Ramasamy, Karthik;
    • Zweegman, Sonja;
    • Spencer, Andrew;
    • Huang, Jeffrey S. Y.;
    • Lu, Jin;
    • Sunami, Kazutaka;
    • Iida, Shinsuke;
    • Chng, Wee-Joo;
    • Holstein, Sarah A.;
    • Rocci, Alberto;
    • Skacel, Tomas;
    • Labotka, Richard
    Publication type:
    Article
    7
    8
    9

    Bortezomib before and after high‐dose therapy in transplant‐eligible patients with newly diagnosed multiple myeloma: Long‐term overall survival after more than 10 years of follow‐up from the phase III HOVON‐65/GMMG‐HD4 trial

    Published in:
    HemaSphere, 2024, v. 8, n. 11, p. 1, doi. 10.1002/hem3.70052
    By:
    • Mai, Elias K.;
    • Nogai, Axel;
    • Lokhorst, Henk M.;
    • van der Holt, Bronno;
    • Zweegman, Sonja;
    • Weisel, Katja C.;
    • Croockewit, Sandra;
    • Jauch, Anna;
    • Hillengass, Jens;
    • Stevens‐Kroef, Marian;
    • Raab, Marc S.;
    • Broijl, Annemiek;
    • Bos, Gerard M. J.;
    • Brossart, Peter;
    • Ypma, Paula;
    • Hanoun, Christine;
    • Bertsch, Uta;
    • Hielscher, Thomas;
    • Salwender, Hans J.;
    • Scheid, Christoph
    Publication type:
    Article
    10

    Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 2, p. 462, doi. 10.1080/10428194.2018.1485915
    By:
    • Qian, Xiaozhong;
    • Amatangelo, Michael;
    • Bjorklund, Chad;
    • Towfic, Fadi;
    • Flynt, Erin;
    • Yu, Xin;
    • Peluso, Teresa;
    • Sternas, Lars;
    • Zaki, Mohamed;
    • Thakurta, Anjan;
    • Dimopoulos, Meletios A.;
    • Weisel, Katja C.;
    • Ocio, Enrique M.;
    • Moreau, Philippe
    Publication type:
    Article
    11
    12

    Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 12, p. 2833, doi. 10.1080/10428194.2016.1177181
    By:
    • Siegel, David S.;
    • Weisel, Katja C.;
    • Dimopoulos, Meletios A.;
    • Baz, Rachid;
    • Richardson, Paul;
    • Delforge, Michel;
    • Song, Kevin W.;
    • San Miguel, Jesus F.;
    • Moreau, Philippe;
    • Goldschmidt, Hartmut;
    • Cavo, Michele;
    • Jagannath, Sundar;
    • Yu, Xin;
    • Hong, Kevin;
    • Sternas, Lars;
    • Zaki, Mohamed;
    • Palumbo, Antonio
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Introduction.

    Published in:
    Annals of the New York Academy of Sciences, 2007, v. 1106, p. xi, doi. 10.1196/annals.1392.026
    By:
    • Weisel, Katja C.;
    • Dick, John E.;
    • Fibbe, Willem E.;
    • Kanz, Lothar
    Publication type:
    Article
    20
    21

    Introduction.

    Published in:
    Annals of the New York Academy of Sciences, 2005, v. 1044, n. 1, p. ix, doi. 10.1196/annals.1349.030
    By:
    • ORLIC, DONALD;
    • WEISEL, KATJA C.;
    • FIBBE, WILLEM E.;
    • KANZ, LOTHAR
    Publication type:
    Article
    22

    Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial.

    Published in:
    Cancers, 2023, v. 15, n. 18, p. 4667, doi. 10.3390/cancers15184667
    By:
    • Leypoldt, Lisa B.;
    • Gavriatopoulou, Maria;
    • Besemer, Britta;
    • Salwender, Hans;
    • Raab, Marc S.;
    • Nogai, Axel;
    • Khandanpour, Cyrus;
    • Runde, Volker;
    • Jauch, Anna;
    • Zago, Manola;
    • Martus, Peter;
    • Goldschmidt, Hartmut;
    • Bokemeyer, Carsten;
    • Dimopoulos, Meletios A.;
    • Weisel, Katja C.
    Publication type:
    Article
    23

    Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.

    Published in:
    Cancers, 2021, v. 13, n. 19, p. 4856, doi. 10.3390/cancers13194856
    By:
    • Klein, Eva-Maria;
    • Tichy, Diana;
    • Salwender, Hans J.;
    • Mai, Elias K.;
    • Duerig, Jan;
    • Weisel, Katja C.;
    • Benner, Axel;
    • Bertsch, Uta;
    • Akhavanpoor, Mabast;
    • Besemer, Britta;
    • Munder, Markus;
    • Lindemann, Hans-Walter;
    • Hose, Dirk;
    • Seckinger, Anja;
    • Luntz, Steffen;
    • Jauch, Anna;
    • Elmaagacli, Ahmet;
    • Fuhrmann, Stephan;
    • Brossart, Peter;
    • Goerner, Martin
    Publication type:
    Article
    24
    25

    Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 561, doi. 10.1111/bjh.17321
    By:
    • Hungria, Vania;
    • Beksac, Meral;
    • Weisel, Katja C.;
    • Nooka, Ajay K.;
    • Masszi, Tamas;
    • Spicka, Ivan;
    • Munder, Markus;
    • Mateos, María‐Victoria;
    • Mark, Tomer M.;
    • Qi, Ming;
    • Qin, Xiang;
    • Fastenau, John;
    • Spencer, Andrew;
    • Sonneveld, Pieter;
    • Garvin, Wendy;
    • Renaud, Thomas;
    • Gries, Katharine S.
    Publication type:
    Article
    26
    27
    28
    29

    Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
    By:
    • Thompson, Michael A.;
    • Boccadoro, Mario;
    • Leleu, Xavier;
    • Vela-Ojeda, Jorge;
    • Rhee, Frits van;
    • Weisel, Katja C.;
    • Rifkin, Robert M.;
    • Usmani, Saad Z.;
    • Hájek, Roman;
    • Cook, Gordon;
    • Abonour, Rafat;
    • Armour, Mira;
    • Morgan, Kathryn E.;
    • Yeh, Su-Peng;
    • Costello, Caitlin L.;
    • Berdeja, Jesus G.;
    • Davies, Faith E.;
    • Zonder, Jeffrey A.;
    • Lee, Hans C.;
    • Omel, Jim
    Publication type:
    Article
    30
    31
    32